Business Context and Reporting Period
Company: Inmune Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 27, 2026
Event: Regulation FD Disclosure regarding the furnishing of an Investor Presentation (Exhibit 99.1).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the availability of an investor presentation and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing is procedural, intended to make the Investor Presentation available to the public under Regulation FD.
Guidance, Outlook, and Risks
Management Commentary: The Company has prepared a slide deck for use in presentations from time to time.
Legal Status of Information: The information contained in Item 7.01 and Exhibit 99.1 is furnished and shall not be deemed "filed" under Section 18 of the Exchange Act. It is not subject to the liabilities of that section and shall not be incorporated by reference into any other filings under the Securities Act or the Exchange Act.
Investor Verification Checklist
- Review the attached Investor Presentation (Exhibit 99.1) for specific operational updates, pipeline data, or financial projections.
- Verify that the presentation content is not incorporated by reference into other SEC filings.
- Check subsequent filings (e.g., 10-K or 10-Q) for formal financial data, as this 8-K contains no numerical financial metrics.